Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphoma × 30 days × Clear all

Phase

Phase 2 36 Phase 1/2 15 Phase 1 13 Phase NA 11 Phase 3 6 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 10 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Non-Small-Cell Lung 7 Recurrence 6 Prostatic Neoplasms 5 Neoplasms 5 Head and Neck Neoplasms 5 Oropharyngeal Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Lung Neoplasms 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Myasthenia Gravis 3 Mouth Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Anorexia 3 Adenocarcinoma Of Esophagus 3 Weight Loss 2 Stomach Neoplasms 2 Peritoneal Neoplasms 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Glioblastoma 2 Fatigue 2

Interventions

Vincristine 1 Rituximab 1 Prednisone 1 Methotrexate 1 Etoposide 1 Cytarabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02405676 2026-03-19

BNHL-2015

Children's Cancer Group, China

Phase 2/3 Active not recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡